Here is a list of this morning’s top companies upgrades, downgrades, and initiations by brokerage firms.
Upgrades:
- American Medical Systems (AMMD) upgraded to Buy from Hold at Stifel Nicolaus; price target $23
- DTS (DTSI) upgraded to Hold from Sell at Collins Stewart
- Elan (ELN) upgraded to Neutral from Sell at UBS
- Electronic Arts (ERTS) upgraded to Neutral from Underweight at Piper Jaffray
- NVIDIA (NVDA) upgraded to Buy from Hold at ThinkEquity
- Sprint Nextel (S) upgraded to Buy from Hold at Deutsche Bank
Downgrades:
- Eldorado Gold (EGO) downgraded to Neutral from Buy at UBS
- Intel (INTC) downgraded to Hold from Buy at ThinkEquity
- InterMune (ITMN) downgraded to Perform from Outperform at Oppenheimer, Wells Fargo, JMP Securities & Neutral from Overweight at JP Morgan — price target $13 from $60
- Merck (MRK) downgraded to Neutral from Buy at Goldman
- Myriad Genetics (MYGN) downgraded to Hold from Buy at Citigroup & Perform from Outperform at JMP Securities
- News Corporation (NWSA) downgraded to Neutral from Overweight at JP Morgan
- Onyx Pharmaceuticals (ONXX) downgraded to Neutral from Outperform at Baird
- STEC (STEC) downgraded to Neutral from Buy at Broadpoint AmTech
- WebMD Health (WBMD) downgraded to Hold from Buy at Canaccord
Coverage Initiated:
- Advanced Micro Devices (AMD) initiated with a Buy at ThinkEquity
- Coldwater Creek (CWTR) initiated with a Buy at Jesup & Lamont; price target $9
- Solarfun Power Holdings (SOLF) initiated with an Outperform at Wells Fargo
Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!
Leave a Reply